US 8815928
Hepatitis C virus inhibitors
granted A61PA61P31/14
Quick answer
US patent 8815928 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P31/14